Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-06-12 | 2022-07-15 | 162472 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-07-11 | 2022-08-19 | 164373 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2019-12-05 | 2020-01-22 | 100262 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-06-04 | 2021-06-14 | 140417 |
| APO-ATORVASTATIN | 40MG | TABLET | Avoided shortage | 2021-12-17 | 2022-01-18 | 151342 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-01-21 | 2022-03-14 | 153267 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-03-19 | 2021-04-12 | 136016 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2025-04-17 | 2025-05-02 | 255194 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2017-06-19 | 2017-08-08 | 13305 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2017-07-25 | 2017-09-22 | 16861 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-04-06 | 2023-04-27 | 188976 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2023-12-15 | 2024-04-05 | 213556 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-01-26 | 2024-02-16 | 217478 |
| APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218373 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-03 | 2024-05-24 | 227088 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2018-01-03 | 2018-03-05 | 34829 |
| APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2018-01-03 | 2018-03-05 | 34832 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2017-03-12 | 2017-04-04 | 709 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2017-03-12 | 2017-04-04 | 712 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2017-04-07 | 2017-06-27 | 5891 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NITRAZEPAM | 5MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1110 |
| APO-NITRAZEPAM | 10MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1117 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40947 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2019-01-04 | 2019-01-04 | 71189 |
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
| APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
| APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-OLANZAPINE | 2.5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4738 |
| APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
| APO-OLANZAPINE | 10.0MG | TABLET | Discontinued | 2018-09-08 | 2018-12-18 | 60672 |
| APO-PAROXETINE | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60684 |
| APO-PINDOL TAB 10MG | 10MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154571 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| APO-PINDOL TAB 5MG | 5MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154568 |
| APO-PRAVASTATIN | 20MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71014 |
| APO-PROPRANOLOL | 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1163 |
| APO-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60708 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |